MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial-Reference-Cited by-同舟云学术

MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial

Published:2024-05 Issue:5 Volume:9 Page:448-459
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Timmer Florentine E F,Geboers Bart,Ruarus Alette H,Vroomen Laurien G P H,Schouten Evelien A C,van der Lei Susan,Vos Danielle J W,Dijkstra Madelon,Schulz Hannah H,Bakker Joyce,van den Bemd Bente A T,van den Tol Petrousjka M,Puijk Robbert S,Lissenberg-Witte Birgit I,de Gruijl Tanja D,de Vries Jan J J,Lagerwaard Frank J,Scheffer Hester J,Bruynzeel Anna M E,Meijerink Martijn R

Funder

Adessium Foundation

Publisher

Elsevier BV

Reference39 articles.

1. Pancreatic cancer;Mizrahi;Lancet,2020

2. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis;Suker;Lancet Oncol,2016

3. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial;Loehrer;J Clin Oncol,2011

4. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology;Tempero;J Natl Compr Canc Netw,2021

5. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Conroy;Ann Oncol,2023

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial: Authors' reply;The Lancet Gastroenterology & Hepatology;2024-08

2. Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial;The Lancet Gastroenterology & Hepatology;2024-08

3. Local ablation in pancreatic cancer: some answers and more questions;The Lancet Gastroenterology & Hepatology;2024-05

4. MRI-guided Stereotactic Ablative Radiotherapy versus CT-guided Irreversible Electroporation in Advanced Pancreatic Cancer: Insights from the CROSSFIRE Trial;Radiology: Imaging Cancer;2024-05-01